Cognitive Training Intervention and Attitudes Towards Genetics

Recruiting now · Not applicable

Conditions studied: Cognitive Impairment, Hematologic Neoplasms, Hematopoietic Cell Transplant

In brief

A pilot study to evaluate feasibility of enrollment of patients in an intervention to improve neurocognitive function in hematopoietic cell transplantation (HCT) survivors using the cognitive training Lumosity program. In addition, patients' interest in receiving information regarding genetic risk of cognitive impairment post-HCT will be measured.

Key facts

Study ID

NCT03094026

Run by

University of Alabama at Birmingham

People needed

60

Starts

2017-08-21

Expected to finish

2027-07-01

Last updated by the study team

2026-04-20

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ≥ 21 years old at time of allogeneic HCT performed at UAB
• Outpatient and between 3 and 6 months post HCT
• English speaking
• Possess access to an internet-connected home computer

You may not qualify if…

• History of pre-existing neurological disorder or documented major psychiatric disorder; significant auditory, visual, or motor impairments
• Participated in neuropsychological intervention within the past 6 months
• History of color blindness

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.